Epsilogen raised €37M in a Series B round in Mar 2022. The company is based in London, UK. Investors in the round: 3B Future Health Fund, British Patient Capital, Caribou Property and 2 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
